Global Influenza Testing Market By Test Type (Traditional Diagnostic Tests, Molecular Diagnostic Tests), Product (Point-Of-Care Testing, Immunodiagnostics, Molecular Diagnostics), Type-of-Flu (Type A Flu, Type B Flu, Type C Flu), End User (Hospitals/Clinical Laboratories, Reference Laboratories, Other End Users), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa), Market Trends & Forecast to 2027
Market Analysis and Insights: Global Influenza Testing Market
Influenza testing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 1006.86 million by 2027 growing at a CAGR of 8.4% in the above-mentioned forecast period. The growth of this market is owing to multiple factors such as rise in contagious respiratory infection, increase in the geriatric population.
Influenza is a type of flu which is caused by virus. It is a communicable disease spread when people come in contact with the affected person. Influenza testing is done to check the main reason of the disease and proper diagnosis is being started to cure the patient.
The growing incidence of influenza diseases due to influenza virus is expected to drive the market growth for influenza testing. With the introduction of the quadrivalent influenza vaccine, the market is attaining high growth. Increasing focus on quality of healthcare, the growing concern of faster diagnosis and influenza control are among the major factors that will impact this market’s growth in the forecast period to 2027.
This market report provides details of market share, new developments, product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Influenza Testing Market Scope and Market Size
Influenza testing market is segmented of the basis of product, test type, type of flu and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on product, market is segmented into point-of-care testing, immunodiagnostics and molecular diagnostics.
Global influenza testing market has also been segmented based on the test type into traditional diagnostic tests and molecular diagnostic tests. Traditional diagnostic tests are further segmented into rapid influenza detection tests (RIDT), viral culture, direct fluorescent antibody (DFA) tests and serological assays. Molecular diagnostic tests are further segmented into RT-PCR, nucleic acid sequence-based amplification (NASBA) tests, loop-mediated isothermal amplification-based assays (LAM), simple amplification-based assays (SAMBA) and other molecular diagnostic tests.
Based on type of flu, the market is segmented into type A flu, type B flu and type C flu.
Global influenza testing market has also been segmented based on the end-user into hospitals/clinical laboratories, reference laboratories and other end users.
Influenza Testing Market Country Level Analysis
Global influenza testing market is analysed and market size insights and trends are provided by country, product, test type, type of flu and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to the large market share of U.S. in the influenza testing market while due to the occurrence of influenza and advanced healthcare facilities, the Asia-Pacific region is expected to grow at the highest growth rate in the forecast period 2020 to 2027 due to the increasing demand of the advanced diagnostic technologies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while provided forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Global influenza testing market report also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for influenza testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the influenza testing market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Influenza Testing Market Share Analysis
Global influenza testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to influenza testing market.
The major players covered in the report are Abbott, BD, CorisBioconcept SPRL, F. Hoffmann-La Roche Ltd, Luminex Corporation, Meridian Bioscience, Inc., Quidel Corporation, Sekisui Diagnostics, Thermo Fisher Scientific Inc, Analytik Jena AG, bioMérieux SA, Cepheid, GenMark Diagnostics, Inc., SA Scientific, QIAGEN and BODITECH MED INC among other players domestic and global. Market share data is available for Global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Influenza Testing Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.